RT @ranitmd: @GUFamilyMed Dr. Dan Merenstein discusses study showing most drugs used in primary care initially studied in non-primary car…
@GUFamilyMed Dr. Dan Merenstein discusses study showing most drugs used in primary care initially studied in non-primary care settings more here: https://t.co/N6ZE2pS48p @NAPCRG #NAPCRG18 https://t.co/RjpXBnO0WE
RT @JournalGIM: Clinical trials supporting #FDA approval of new drugs most commonly used in #primarycare settings are often unclear on tria…
RT @JournalGIM: Clinical trials supporting #FDA approval of new drugs most commonly used in #primarycare settings are often unclear on tria…
RT @JournalGIM: Clinical trials supporting #FDA approval of new drugs most commonly used in #primarycare settings are often unclear on tria…
Clinical trials supporting #FDA approval of new drugs most commonly used in #primarycare settings are often unclear on trial setting; only 8% clearly conducted at least in part in a primary care setting #clinicaltrials @GUMedicine @YaleMed https://t.co/PRO
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
RT @JoshuaDWallach: Interesting new @JournalGIM paper suggests new drugs approved by FDA "predominantly supported by evidence generated in…
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
RT @JoshuaDWallach: Interesting new @JournalGIM paper suggests new drugs approved by FDA "predominantly supported by evidence generated in…
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
RT @JoshuaDWallach: Interesting new @JournalGIM paper suggests new drugs approved by FDA "predominantly supported by evidence generated in…
RT @JoshuaDWallach: Interesting new @JournalGIM paper suggests new drugs approved by FDA "predominantly supported by evidence generated in…
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
RT @JoshuaDWallach: Interesting new @JournalGIM paper suggests new drugs approved by FDA "predominantly supported by evidence generated in…
RT @JoshuaDWallach: Interesting new @JournalGIM paper suggests new drugs approved by FDA "predominantly supported by evidence generated in…
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
Interesting new @JournalGIM paper suggests new drugs approved by FDA "predominantly supported by evidence generated in sub-specialty settings, despite that most end users of these therapies will likely be patients and prescribers in primary care setting" h
RT @jsross119: New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducte…
New paper in @JournalGIM: pivotal trials of drugs approved by FDA primarily for use in primary care settings rarely conducted in primary care (when we could figure it out); imp implications for expected benefits/risk in real-world https://t.co/tWTxZt5pYO h
Our research report is now published online! Hope it draws attention to important feature of trials that if overlooked may lead to poor outcomes #testdrugswheretheyaremostoftenused #AcademicTwitter https://t.co/96EisTW3wn
Review of clinical trial settings of drugs commonly used in primary care and approved between 2005 and 2012 https://t.co/7TOpClvHSB